Pedro Costa is a researcher, inventor, educator and entrepreneur. He is the founder, CEO and CTO of the company BIOFABICS, which is specialized in the creation of 3D biotissue analogues.

Before that, he was the coordinator of the world’s first MSc Programme in Biofabrication at Utrecht University, manager of the Utrecht Biofabrication Facility and postdoctoral researcher at the University Medical Center Utrecht (Netherlands).

Dr. Costa can be described as a biologist by training and engineer/maker by heart, given his undergraduate studies in applied biology followed by a PhD in biomedical engineering where he specialized in the application/combination of highly automated tools such as additive manufacturing (3D bioprinting) and bioreactor technologies in the field of tissue engineering and regenerative medicine. He has previously worked in both academic and industrial environments in places such as Portugal (University of Minho), Belgium (Materialise NV), Australia (Queensland University of Technology) and Germany (Technical University of Munich).

Finally, Dr. Costa has received several awards for his work, among them the 2014 ESB Translational Award and the 2016 ISBF Young Investigator Award (2nd place).